Project Grant HT94252410121
Award Date
6/1/24
Completion Date
5/31/26
Dollars Obligated
$311K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Iowa City, IA 52242, USA
Similar Awards
The University of Iowa was awarded a $1,529,022 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will fund research from February 2021 to February 2024 to investigate SUMO inhibition and its ability to repress mammary oncogenesis through the ETV1 protein. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
The University of Iowa received a $155,500 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant funding will support a targeted approach to inhibiting the NRF2 pathway in neuroendocrine cancers. This award, with a performance period from November 1, 2024 to October 31, 2026, is part of the program's efforts to transform healthcare for military service members and the general public...
The University of Iowa was awarded a $1.3 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year award will support preclinical development of use-dependent selective blockers of GluA2-lacking AMPA receptors to prevent noise-induced neurodegeneration. The goal is to investigate medical solutions for the battlefield by transforming health care for service members and the public through innovative biomedical...
The University of Iowa will receive $772,480 under a three-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research to delineate novel molecular pathways critical for the growth of GNAQ/11-mutant uveal melanoma cells. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through innovative...
The University of Iowa was awarded a $777,500.00 Project Grant from the Defense Health Agency to conduct research under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on August 1, 2023, will fund a 3-year project to identify genetic mechanisms driving the transition of benign nevi to malignant melanoma. As a leading public research university, the University of Iowa has extensive experience delivering high-quality biomedical research, healthcare services,...
The University of Iowa was awarded an $810,971 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The award will fund research from April 2021 through April 2024 to target a protumorigenic immunosuppressive loop in malignant peripheral nerve sheath tumors (MPNST). The Military Medical Research and Development program supports biomedical research that transforms military and public health care through innovative solutions for...
The University of Iowa received a $816,178 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "TARGETED THERAPY FOR MPNST METASTASIS," will support research activities at the University of Iowa from June 1, 2024 to May 31, 2027. The research aims to develop innovative treatments for metastatic malignant peripheral nerve sheath tumors, a rare and aggressive type of cancer. This federal grant...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $748,815 Project Grant to the University of Iowa. The grant, awarded on July 1, 2024, will support the "Women's Health in Tuberous Sclerosis Complex: A Population-Based Assessment of Morbidity to Inform Clinical Care" project. This research aims to provide a comprehensive assessment of the health issues faced by women with tuberous sclerosis complex, a rare genetic disorder, in...
The University of Iowa will validate tRNA viruses to target SCN2A-related autism phenotypes under a three-year, $549,998 Project Grant from the Defense Health Agency's Military Medical Research and Development program. The grant aims to transform military and public health through innovative biomedical research investigating medical solutions for the battlefield and conditions like autism. Specifically, the University will investigate using tRNA viruses to target autism phenotypes related to...
The University of Iowa received a $598,563 Project Grant from the Department of Defense Washington Headquarters Service to support basic scientific research related to or with potential to improve Army programs under the Basic Scientific Research federal grant program (CFDA 12.431). Specifically, the grant will fund research and development of a Constellation Ready Magnetometer from July 1, 2021 to June 30, 2024. The University of Iowa will conduct the research at its location in Iowa City,...